On Tuesday, Following Stocks were among the “Top 50 Gainers” of U.S. Stock Market: Inventergy Global, Inc. (NASDAQ:INVT), Aoxing Pharmaceutical Corporation, Inc. (NYSEMKT:AXN), Hercules Offshore, Inc. (NASDAQ:HERO), Microvision Inc. (NASDAQ:MVIS)
Inventergy Global, Inc. (NASDAQ:INVT), with shares inclined 16.94%, closed at $0.82.
Aoxing Pharmaceutical Corporation, Inc. (NYSEMKT:AXN), with shares jumped 14.84%, settled at $2.09.
Hercules Offshore, Inc. (NASDAQ:HERO), with shares climbed 13.40%, and closed at $0.42.
Microvision Inc. (NASDAQ:MVIS), surged 12.42%, and closed at $3.53, hitting new 52-week high of $3.55.
Latest NEWS regarding these Stocks are depicted underneath:
Inventergy Global, Inc. (NASDAQ:INVT)
On Tuesday, Inventergy Global, Inc. (INVT), declared operational restructuring and process improvements for the product-based businesses of its wholly-owned partner, eOn Communications Systems, Inc. (“ECS”), to plannedally position the corporation to raise earnings, reduce costs, improve cash flow and build shareholder value. ECS is managed by its President Stephen Swartz.
The ECS business has three product/service lines:
- a) A royalty bearing contract with a third party for use of a private branch exchange (PBX) business which they had purchased from Inventergy’s predecessor eOn Communications Corporation (“ECC”);
- b) A valued-added reseller business of biometric security and access control products; and
- c) A new business that provides outsourced sales, marketing and technical support services to business partners in the security products and services industry.
Inventergy Global, Inc. is Silicon Valley-based intellectual property corporation dedicated to identifying, acquiring and licensing the patented technologies of market-noteworthytechnology leaders.
eOn Communications Systems, Inc. is a wholly owned partner of Inventergy Global, Inc. It has a branch office located in Corinth, Mississippi and is headed by Stephen Swartz, the former Principal Executive Officer of eOn Communications Corporation and is engaged in the sale and support of security related products and services.
Aoxing Pharmaceutical Corporation, Inc. (NYSEMKT:AXN)
Last Friday, Aoxing Pharmaceutical Corporation, Inc. (AXN), declared that it has reached contracts to sell 1,029,412 shares of its ordinary stock. The sales are being made for the primary purpose of increasing the shareholders equity of the Corporation, and bringing it into compliance with the continued listing requirements of NYSE MKT. The sales will be accomplished after the NYSE MKT approves the listing of the additional shares.
508,000 shares will be sold to officers and employees of Aoxing Pharma at a price of $1.36 per share, which was the market price when the sales contracts were made on March 11, 2015. Comprised of among the purchasers will be Wilfred Chow, CFO (100,000 shares) and Guoan Zhang, VP-Finance (20,000 shares). The proceeds for Aoxing Pharma total $690,880, which will be utilized for working capital purposes. The additional 521,412 shares will be issued to a creditor in satisfaction of $709,120 debt.
Aoxing Pharmaceutical Corporation, Inc. is a US incorporated specialty pharmaceutical corporation with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-administration products. Headquartered in Shijiazhuang City, outside Beijing, Aoxing Pharma has the largest and most advanced manufacturing facility in China for highly regulated narcotic medicines.
Hercules Offshore, Inc. (NASDAQ:HERO)
Hercules Offshore, Inc. (HERO), gained last day cutting its downward trend on Tuesday, but as Hercules Offshore, Inc. (HERO), has been hard hit by the collapsing price in oil with a Middle East contract cancelled and has been cutting jobs in an attempt to curb costs. Unless oil recovers, the best option is to sell at this time.
Mean recommendation of the analyst for this stock is 3.1.
Hercules Offshore, Inc., together with its auxiliaries, provides shallow-water drilling and marine services to the oil and natural gas exploration and production industry worldwide.
Microvision Inc. (NASDAQ:MVIS)
On Monday, Microvision Inc. (MVIS), declared it has received orders totaling $14.5 million for components for its Fortune Global 100 customer.
MicroVision plans to start shipment of components for these orders in the second half of 2015 and anticipates fulfillment to continue into 2016. MicroVision and its Fortune Global 100 customer recently reached a licensing contract whereby MicroVision granted a non-exclusive license to its patented PicoP® display technology to the Fortune Global 100 corporation. The components MicroVision is selling to its customer are predictable to be incorporated into display modules the Fortune Global 100 has developed. MicroVision will also be entitled to royalty payments upon any sales by its customer of the display modules. MicroVision is presently fulfilling component orders received in the second half of 2014 for this same customer.
MicroVision, Inc. is engaged in the development of its proprietary PicoP display technology that can be used by its customers to create miniature laser display and imaging engines in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
